# Regadenoson

NDC: 85742-012
Generic name: Regadenoson
Labeler / Manufacturer: Kanchan Healthcare Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240822

FDA application: ANDA218054

## Active ingredients

- REGADENOSON: .08 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85742-012"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85742-012
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b183399d-b8dc-4924-90cd-a1c2247742f3